“Bispecific T-Cell Engager Therapy in Relapsed Acute Lymphoblastic Leukemia: A Review of Published Cohorts” (2026) Annals of Leukemia Research, 7(1), pp. 13–18. doi:10.5281/zenodo.22247744.